• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通用型和特定疾病偏好性工具的有效性:区分哮喘控制状态的能力。

The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status.

作者信息

McTaggart-Cowan Helen M, Marra Carlo A, Yang Yaling, Brazier John E, Kopec Jacek A, FitzGerald J Mark, Anis Aslam H, Lynd Larry D

机构信息

Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, 7th Floor, 828 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L8.

出版信息

Qual Life Res. 2008 Apr;17(3):453-62. doi: 10.1007/s11136-008-9309-6. Epub 2008 Feb 15.

DOI:10.1007/s11136-008-9309-6
PMID:18274882
Abstract

OBJECTIVE

A goal of asthma management is to improve the patient's health-related quality of life (HRQL). However, it is unclear whether HRQL instruments can discriminate across asthma control measures. The objective of this study was to evaluate the validity of generic and condition-specific preference-based instruments, in terms of their ability to distinguish asthma control.

METHODS

Asthma patients (n = 157) completed three generic preference-based instruments: the Health Utility Index Mark 3 (HUI-3), the EuroQol (EQ-5D), and the Short Form 6D (SF-6D) and two condition-specific questionnaires: the standardized Asthma Quality of Life Questionnaire (AQLQ(S)) and the Asthma Control Questionnaire (ACQ). The AQLQ(S) scores were converted into the condition-specific preference-based scores: the Asthma Quality of Life Utility Index (AQL-5D).

RESULTS

The preference-based instruments were generally able to discriminate across control measures, such as ACQ scores and magnitude of asthma medication, but were not able to discriminate for self-reported control and severity levels. These instruments also correlated with most control measures (r = 0.32-0.37). Significant relationships between AQL-5D scores and all control variables were observed.

CONCLUSIONS

Overall, the AQL-5D discriminated across all levels of asthma control. The HUI-3, the EQ-5D, and the SF-6D differentiated between the highest and lowest levels of control but could not discriminate between the moderate levels.

摘要

目的

哮喘管理的一个目标是改善患者与健康相关的生活质量(HRQL)。然而,尚不清楚HRQL工具是否能够区分不同的哮喘控制措施。本研究的目的是评估基于偏好的通用工具和特定疾病工具在区分哮喘控制方面的有效性。

方法

哮喘患者(n = 157)完成了三种基于偏好的通用工具:健康效用指数Mark 3(HUI-3)、欧洲五维健康量表(EQ-5D)和简式6D量表(SF-6D),以及两种特定疾病问卷:标准化哮喘生活质量问卷(AQLQ(S))和哮喘控制问卷(ACQ)。AQLQ(S)得分被转换为基于特定疾病偏好的得分:哮喘生活质量效用指数(AQL-5D)。

结果

基于偏好的工具通常能够区分不同的控制措施,如ACQ得分和哮喘药物使用量,但无法区分自我报告的控制和严重程度水平。这些工具也与大多数控制措施相关(r = 0.32 - 0.37)。观察到AQL-5D得分与所有控制变量之间存在显著关系。

结论

总体而言,AQL-5D能够区分哮喘控制的所有水平。HUI-3、EQ-5D和SF-6D能够区分最高和最低控制水平,但无法区分中等控制水平。

相似文献

1
The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status.通用型和特定疾病偏好性工具的有效性:区分哮喘控制状态的能力。
Qual Life Res. 2008 Apr;17(3):453-62. doi: 10.1007/s11136-008-9309-6. Epub 2008 Feb 15.
2
Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.在哮喘中,特定疾病效用值是否比基于通用偏好的效用值更有效?一项比较EQ-5D-3L、SF-6D与AQL-5D的研究证据。
Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):667-675. doi: 10.1080/14737167.2018.1505506. Epub 2018 Aug 3.
3
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.类风湿关节炎中通用间接效用测量方法(健康效用指数2、健康效用指数3、SF-6D和欧洲五维度健康量表)与疾病特异性工具(类风湿关节炎生活质量量表和健康评估问卷)的比较。
Soc Sci Med. 2005 Apr;60(7):1571-82. doi: 10.1016/j.socscimed.2004.08.034.
4
Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes.哮喘效用的测量:有证据表明通用工具可能会遗漏临床上的重要变化。
Qual Life Res. 2016 Dec;25(12):3017-3026. doi: 10.1007/s11136-016-1357-8. Epub 2016 Jul 7.
5
Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.SF-6D 和 EQ-5D 效用评分在治疗盆腔器官脱垂中的反应性和最小重要差异。
Am J Obstet Gynecol. 2019 Mar;220(3):265.e1-265.e11. doi: 10.1016/j.ajog.2018.11.1094. Epub 2018 Nov 22.
6
A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.类风湿关节炎患者使用 EQ-5D 和 SF-6D 偏好型通用量表进行效用测量的比较。
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):661-71. Epub 2011 Aug 31.
7
A review of the psychometric properties of generic utility measures in multiple sclerosis.多发性硬化症中通用效用测量的心理测量特性综述。
Pharmacoeconomics. 2014 Aug;32(8):759-73. doi: 10.1007/s40273-014-0167-5.
8
Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.稳定型心绞痛患者中欧洲五维度健康量表(EQ - 5D)与简短健康调查简表6维度(SF - 6D)的验证与比较
Health Qual Life Outcomes. 2014 Oct 25;12:156. doi: 10.1186/s12955-014-0156-6.
9
The use of rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D.运用 Rasch 分析减少大型特定条件下偏好估值工具的使用:从 AQLQ 到 AQL-5D 的案例。
Med Decis Making. 2011 Jan-Feb;31(1):195-210. doi: 10.1177/0272989X10364846. Epub 2010 Jun 4.
10
Validity and Responsiveness of EQ-5D in Asthma: A Systematic Review and Meta-analysis.EQ-5D在哮喘中的有效性和反应性:一项系统评价和荟萃分析。
Patient. 2025 Jan;18(1):35-47. doi: 10.1007/s40271-024-00711-9. Epub 2024 Sep 7.

引用本文的文献

1
Are EQ-5D-Y-3L and EQ-5D-Y-5L Useful Tools to Assess Health Outcomes in Children With Asthma? An Analysis of Child and Parental Carer Reporting.EQ-5D-Y-3L和EQ-5D-Y-5L是评估哮喘儿童健康结局的有用工具吗?一项儿童及家长报告的分析。
Pediatr Pulmonol. 2025 Mar;60(3):e71031. doi: 10.1002/ppul.71031.
2
Health-related quality of life in adult patients with asthma according to asthma control and severity: A systematic review and meta-analysis.根据哮喘控制情况和严重程度评估成年哮喘患者的健康相关生活质量:一项系统评价和荟萃分析。
Front Pharmacol. 2022 Nov 21;13:908837. doi: 10.3389/fphar.2022.908837. eCollection 2022.
3

本文引用的文献

1
A power primer.强力底漆。
Psychol Bull. 1992 Jul;112(1):155-9. doi: 10.1037//0033-2909.112.1.155.
2
Should patients have a greater role in valuing health states?患者在评估健康状态方面是否应发挥更大作用?
Appl Health Econ Health Policy. 2005;4(4):201-8. doi: 10.2165/00148365-200504040-00002.
3
Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey.加拿大全国人口健康调查中与糖尿病及合并症相关的健康相关生活质量缺陷
Measurement properties of the EQ-5D-Y administered through a smartphone app in children with asthma: a longitudinal questionnaire study.
哮喘儿童通过智能手机应用程序使用 EQ-5D-Y 的测量性能:纵向问卷调查研究。
Health Qual Life Outcomes. 2022 Mar 28;20(1):51. doi: 10.1186/s12955-022-01955-5.
4
How does the EQ-5D-5L perform in asthma patients compared with an asthma-specific quality of life questionnaire?EQ-5D-5L 在哮喘患者中的表现与哮喘特异性生活质量问卷相比如何?
BMC Pulm Med. 2020 Jun 13;20(1):168. doi: 10.1186/s12890-020-01205-8.
5
Effect of asthma control on general health-related quality of life in patients diagnosed with adult-onset asthma.哮喘控制对成年起病哮喘患者一般健康相关生活质量的影响。
Sci Rep. 2019 Nov 6;9(1):16107. doi: 10.1038/s41598-019-52361-9.
6
The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics.急性哮喘患者 EQ-5D-5L、AQL-5D 和定制 TTO 的结构效度和反应度。
Qual Life Res. 2020 Mar;29(3):619-627. doi: 10.1007/s11136-019-02345-z. Epub 2019 Nov 2.
7
Study protocol to develop a patient-reported outcome measuring disability associated with unilateral vocal fold paralysis: a mixed-methods approach with the CoPE collaborative.研究方案:开发一种用于评估单侧声带麻痹相关残疾的患者报告结局测量工具:采用 CoPE 协作的混合方法。
BMJ Open. 2019 Oct 30;9(10):e030151. doi: 10.1136/bmjopen-2019-030151.
8
EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.欧洲五维度健康量表(EQ-5D-5L)在评估成人哮喘患者生活质量中的效度:横断面研究
J Med Internet Res. 2019 Jan 23;21(1):e10178. doi: 10.2196/10178.
9
Impact of asthma on women and men: Comparison with the general population using the EQ-5D-5L questionnaire.哮喘对男性和女性的影响:使用 EQ-5D-5L 问卷与普通人群进行比较。
PLoS One. 2018 Aug 23;13(8):e0202624. doi: 10.1371/journal.pone.0202624. eCollection 2018.
10
Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.EQ-5D 在哮喘中的适用性如何?从患者角度看可接受性和内容效度。
Health Qual Life Outcomes. 2018 Aug 3;16(1):160. doi: 10.1186/s12955-018-0970-3.
Qual Life Res. 2005 Jun;14(5):1311-20. doi: 10.1007/s11136-004-6640-4.
4
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.布地奈德/福莫特罗联合疗法作为哮喘的维持和缓解药物
Am J Respir Crit Care Med. 2005 Jan 15;171(2):129-36. doi: 10.1164/rccm.200407-884OC. Epub 2004 Oct 22.
5
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.能否实现指南定义的哮喘控制?“获得最佳哮喘控制”研究。
Am J Respir Crit Care Med. 2004 Oct 15;170(8):836-44. doi: 10.1164/rccm.200401-033OC. Epub 2004 Jul 15.
6
Psychometric and utility-based measures of health status of asthmatic patients with different disease control level.不同疾病控制水平的哮喘患者健康状况的心理测量和基于效用的测量
Pharmacoeconomics. 2004;22(8):537-47. doi: 10.2165/00019053-200422080-00005.
7
Association between preference-based health-related quality of life and asthma severity.基于偏好的健康相关生活质量与哮喘严重程度之间的关联。
Ann Allergy Asthma Immunol. 2004 Mar;92(3):329-34. doi: 10.1016/S1081-1206(10)61570-0.
8
Formoterol used as needed improves health-related quality of life in asthmatic patients uncontrolled with inhaled corticosteroids.按需使用福莫特罗可改善吸入糖皮质激素治疗效果不佳的哮喘患者的健康相关生活质量。
Respir Med. 2003 Sep;97(9):1061-6. doi: 10.1016/s0954-6111(03)00138-0.
9
A comparative review of four preference-weighted measures of health-related quality of life.四种健康相关生活质量偏好加权测量方法的比较综述
J Clin Epidemiol. 2003 Apr;56(4):317-25. doi: 10.1016/s0895-4356(02)00609-1.
10
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.最小重要差异与健康状态效用值之间的关系是什么?以SF-6D为例。
Health Qual Life Outcomes. 2003 Apr 11;1:4. doi: 10.1186/1477-7525-1-4.